List of Excipients in API HYDROXYZINE PAMOATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing HYDROXYZINE PAMOATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | D&C RED NO. 33 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | D&C YELLOW NO. 10 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | FD&C GREEN NO. 3 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | FD&C YELLOW NO. 6 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing HYDROXYZINE PAMOATE
Detailed excipient profiles for HYDROXYZINE PAMOATE
Excipient focus: ALCOHOL
HYDROXYZINE PAMOATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydroxyzine pamoate | 53808-0373 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
HYDROXYZINE PAMOATE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | hydroxyzine pamoate | 52959-433 |
| Direct Rx | hydroxyzine pamoate | 61919-357 |
| TYA Pharmaceuticals | hydroxyzine pamoate | 64725-0302 |
| RedPharm Drug Inc | hydroxyzine pamoate | 67296-0152 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
HYDROXYZINE PAMOATE drug variants containing AMMONIA
HYDROXYZINE PAMOATE drug variants not containing AMMONIA
Excipient focus: ANHYDROUS LACTOSE
HYDROXYZINE PAMOATE drug variants containing ANHYDROUS LACTOSE
HYDROXYZINE PAMOATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
HYDROXYZINE PAMOATE drug variants containing BUTYL ALCOHOL
HYDROXYZINE PAMOATE drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
HYDROXYZINE PAMOATE drug variants containing CELLULOSE, MICROCRYSTALLINE
HYDROXYZINE PAMOATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
HYDROXYZINE PAMOATE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | hydroxyzine pamoate | 42549-528 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
HYDROXYZINE PAMOATE drug variants containing CROSCARMELLOSE SODIUM
HYDROXYZINE PAMOATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 28
HYDROXYZINE PAMOATE drug variants containing D&C RED NO. 28
HYDROXYZINE PAMOATE drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
HYDROXYZINE PAMOATE drug variants containing D&C RED NO. 33
HYDROXYZINE PAMOATE drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
HYDROXYZINE PAMOATE drug variants containing D&C YELLOW NO. 10
HYDROXYZINE PAMOATE drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydroxyzine pamoate | 53808-0373 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
HYDROXYZINE PAMOATE drug variants containing FD&C BLUE NO. 1
HYDROXYZINE PAMOATE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
HYDROXYZINE PAMOATE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Eon Labs Inc | hydroxyzine pamoate | 0185-0674 |
| Teva Pharmaceuticals USA Inc | hydroxyzine pamoate | 0555-0323 |
| Apotheca Inc | hydroxyzine pamoate | 12634-833 |
| Correct Rx Pharmacy Services Inc | hydroxyzine pamoate | 24555-0674 |
| PD-Rx Pharmaceuticals Inc | hydroxyzine pamoate | 43063-172 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
HYDROXYZINE PAMOATE drug variants containing FD&C GREEN NO. 3
HYDROXYZINE PAMOATE drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 40
HYDROXYZINE PAMOATE drug variants containing FD&C RED NO. 40
HYDROXYZINE PAMOATE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
HYDROXYZINE PAMOATE drug variants containing FD&C YELLOW NO. 6
HYDROXYZINE PAMOATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERROSOFERRIC OXIDE
HYDROXYZINE PAMOATE drug variants containing FERROSOFERRIC OXIDE
HYDROXYZINE PAMOATE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: FERROUS OXIDE
HYDROXYZINE PAMOATE drug variants containing FERROUS OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydroxyzine pamoate | 53808-0426 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing FERROUS OXIDE
Excipient focus: GELATIN
HYDROXYZINE PAMOATE drug variants containing GELATIN
HYDROXYZINE PAMOATE drug variants not containing GELATIN
Excipient focus: HYDROXYPROPYL CELLULOSE
HYDROXYZINE PAMOATE drug variants containing HYDROXYPROPYL CELLULOSE
HYDROXYZINE PAMOATE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: INDIGOTINDISULFONATE SODIUM
HYDROXYZINE PAMOATE drug variants containing INDIGOTINDISULFONATE SODIUM
HYDROXYZINE PAMOATE drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: ISOPROPYL ALCOHOL
HYDROXYZINE PAMOATE drug variants containing ISOPROPYL ALCOHOL
HYDROXYZINE PAMOATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
HYDROXYZINE PAMOATE drug variants containing LACTOSE MONOHYDRATE
HYDROXYZINE PAMOATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
HYDROXYZINE PAMOATE drug variants containing MAGNESIUM STEARATE
HYDROXYZINE PAMOATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
HYDROXYZINE PAMOATE drug variants containing PROPYLENE GLYCOL
HYDROXYZINE PAMOATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
HYDROXYZINE PAMOATE drug variants containing SHELLAC
HYDROXYZINE PAMOATE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
HYDROXYZINE PAMOATE drug variants containing SILICON DIOXIDE
HYDROXYZINE PAMOATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
HYDROXYZINE PAMOATE drug variants containing SODIUM LAURYL SULFATE
HYDROXYZINE PAMOATE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
HYDROXYZINE PAMOATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
HYDROXYZINE PAMOATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
HYDROXYZINE PAMOATE drug variants containing STARCH, CORN
HYDROXYZINE PAMOATE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
HYDROXYZINE PAMOATE drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | hydroxyzine pamoate | 0069-5410 |
| Greenstone LLC | hydroxyzine pamoate | 59762-5420 |
| REMEDYREPACK INC | hydroxyzine pamoate | 70518-0500 |
| REMEDYREPACK INC | hydroxyzine pamoate | 70518-3323 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing SUCROSE
Excipient focus: TITANIUM DIOXIDE
HYDROXYZINE PAMOATE drug variants containing TITANIUM DIOXIDE
HYDROXYZINE PAMOATE drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
